Clearmind Medicine (CMND) Invested Capital (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Invested Capital of $97801.0 for Q2 2026, down 82.56% year-over-year from $560723.0 in Q2 2025, and down 57.05% quarter-over-quarter from $227684.0 in Q1 2026.
Clearmind Medicine (CMND) Invested Capital (2021 - 2026) Analysis & Trends
Clearmind Medicine's Invested Capital history runs 6 years deep, the most recent figure standing at $97801.0 for Q2 2026.
- In Q2 2026, Invested Capital fell 82.56% year-over-year to $97801.0; the TTM figure through Apr 2026 stood at $1.1 million (down 44.06% YoY), while the FY2025 annual figure was $60232.0, down 90.41% from the prior year.
- Invested Capital for Q2 2026 stood at $97801.0, down from $227684.0 in the prior quarter.
- The five-year high for Invested Capital was $1.2 million in Q4 2022, with the low at $41591.0 in Q3 2023.
- The 5-year median for Invested Capital is $394203.5 (2025), against an average of $436655.5.
- The sharpest annual moves came in 2022 and 2023: Invested Capital soared 2579.46% in 2022, then plunged 96.57% in 2023.
- Clearmind Medicine's Invested Capital stood at $1.2 million in 2022, then slumped by 96.57% to $42433.0 in 2023, then surged by 1380.36% to $628160.0 in 2024, then tumbled by 90.41% to $60232.0 in 2025, then jumped by 62.37% to $97801.0 in 2026.
- Business Quant data shows CMND's Invested Capital at $97801.0 in Q2 2026, $227684.0 in Q1 2026, and $60232.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | 405,315.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 97,801.00 |
| Jan 31, 2026 | 227,684.00 |
| Oct 31, 2025 | 60,232.00 |
| Jul 31, 2025 | 725,178.00 |
| Apr 30, 2025 | 560,723.00 |
| Jan 31, 2025 | 748,250.00 |
| Oct 31, 2024 | 628,160.00 |
| Jul 31, 2024 | 48,577.00 |
| Apr 30, 2024 | 47,009.00 |
| Jan 31, 2024 | 854,834.00 |
| Oct 31, 2023 | 42,433.00 |
| Jul 31, 2023 | 41,591.00 |
| Jan 31, 2023 | 794,567.97 |
| Oct 31, 2022 | 1.24 Mn |
| Oct 31, 2021 | 46,133.80 |